Stopping viral disease spread relies on accurate, cost efficient and robust community detection. Multiplexed tools that are responsive to viral mutations remove the need for iterative devices, and equip public health practitioners with test-to-treat tools that detect infection at early stages of disease, and stop an outbreak before it begins. 

Enter, the Freeman Lab with the GlycoGrip2.0, a device intended to ensure healthy lives and promote well-being for all at all ages – aligned with Goal 3 of the UN’s 17 Sustainable Development Goals.

This multiplex test uses sugars ensnare the virus, causing the test strip to display a line or dot indicating the virus tested for is present. In this video, you can see the strides this project, spearheaded by Drs. Freeman and Kim, has taken to transform the device from a single to a multi-disease array that is effective, robust, and handheld the size of a stick of gum – with the potential to test multiple classes of viruses – from respiratory to sexually transmitted infections.

To learn more about this technology, and to read the peer reviewed papers for the GlycoGrip, visit our Sensors page.